Cellular Bioengineering
Total Raised
$4.84MDeal Terms
2Funding, Valuation & Revenue
4 Fundings
Cellular Bioengineering's latest funding round was a Convertible Note for $2M on January 27, 2014.
Cellular Bioengineering's valuation in April 2004 was $4.76M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
1/27/2014 | Convertible Note | $2M | Undisclosed Investors | 1 | ||
1/20/2006 | Series B | |||||
1/25/2005 | Series A - II | |||||
4/15/2004 | Series A | $4.76M |
Date | 1/27/2014 | 1/20/2006 | 1/25/2005 | 4/15/2004 |
|---|---|---|---|---|
Round | Convertible Note | Series B | Series A - II | Series A |
Amount | $2M | |||
Investors | Undisclosed Investors | |||
Valuation | $4.76M | |||
Revenue | ||||
Sources | 1 |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
Cellular Bioengineering Deal Terms
2 Deal Terms
Cellular Bioengineering's deal structure is available for 2 funding rounds, including their Series B from January 20, 2006.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.